ClinVar Miner

Submissions for variant NM_001110792.2(MECP2):c.961C>T (p.Arg321Trp)

dbSNP: rs61751444
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 24
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel RCV000170241 SCV002569941 pathogenic Rett syndrome 2022-07-28 reviewed by expert panel curation The c.925C>T p.(Arg309Trp) variant in MECP2 (NM_004992.3) is absent from gnomAD (PM2_supporting). The p.(Arg309Trp) variant has been observed in at least 5 individuals, including males, with variable neurodevelopmental phenotypes consistent with MECP2-related disease (PMID 26936630, 29655203, 29720203, 28837158, 31178897, 30536762, 32214227) (PS4, PP4). One of the reported individuals with this variant was also found to be heterozygous for a de novo (biological parentage confirmed) SMC3 frameshift variant (PMID 31178897). The p.(Arg309Trp) variant has been reported as a de novo occurrence (biological parentage both confirmed and unconfirmed) in at least 3 of these individuals (PMID 31178897, 26936630) (PS2_very strong). Additional family studies have found the p.(Arg309Trp) variant to be maternally inherited in at least 2 cases (PMID 29720203, 26936630), and inherited from an unaffected mosaic parent in at least 1 case (PMID 28837158). Computational prediction analysis tools are inconclusive for this variant. In summary, the c.925C>T p.(Arg309Trp) variant in MECP2 is classified as Pathogenic for MECP2-related disease based on the ACMG/AMP criteria (PS2_very strong, PS4, PM2_supporting, PP4).
GeneDx RCV000133293 SCV000190988 pathogenic not provided 2021-10-25 criteria provided, single submitter clinical testing In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 28027854, 20479760, 21160487, 17084570, 23810759, 26936630, 28089766, 30536762, 29655203, 29720203, 28837158, 31178897, 32214227)
Genetic Services Laboratory, University of Chicago RCV000170241 SCV000248007 pathogenic Rett syndrome 2017-06-22 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000133293 SCV000343620 likely pathogenic not provided 2016-10-26 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000133293 SCV000575669 pathogenic not provided 2020-02-01 criteria provided, single submitter clinical testing
Ambry Genetics RCV000624661 SCV000741171 likely pathogenic Inborn genetic diseases 2015-12-14 criteria provided, single submitter clinical testing
Baylor Genetics RCV000169947 SCV000807252 pathogenic X-linked intellectual disability-psychosis-macroorchidism syndrome 2017-09-01 criteria provided, single submitter clinical testing This variant has been previously reported as disease-causing and was found four times in our laboratory (in 3 males and 1 female): maternally inherited in a 6-year-old male with global delays, stereotypic hand movements, hypotonia, failure to thrive; de novo in a 3-year-old female with global delays and hypotonia; maternally inherited in a 4-year-old male with gloabal delays, dysmorphisms, short stature, macrocehaly, retractile testis, hypothyroidism; de novo in a 2-year-old male with global delay, hypotonia, epilepsy, relative macrocephaly
Mayo Clinic Laboratories, Mayo Clinic RCV000170241 SCV000809080 likely pathogenic Rett syndrome 2018-04-12 criteria provided, single submitter clinical testing
Biochemistry Laboratory of CDMU, Chengde Medical University RCV000170241 SCV000899194 likely pathogenic Rett syndrome criteria provided, single submitter case-control
Department of Genetics, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine RCV000851523 SCV000994583 pathogenic Intellectual disability 2019-04-05 criteria provided, single submitter clinical testing
Invitae RCV001049007 SCV001213039 pathogenic Severe neonatal-onset encephalopathy with microcephaly 2023-12-30 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 309 of the MECP2 protein (p.Arg309Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with intellectual disability and/or clinical characteristics of Rett syndrome (PMID: 17084570, 20479760, 21160487, 23810759, 26936630, 29720203, 30536762). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 143749). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MECP2 protein function. For these reasons, this variant has been classified as Pathogenic.
Genomic Research Center, Shahid Beheshti University of Medical Sciences RCV000170241 SCV001251808 pathogenic Rett syndrome 2020-05-03 criteria provided, single submitter clinical testing
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV000133293 SCV001446400 pathogenic not provided 2020-10-23 criteria provided, single submitter clinical testing
Laboratoire Génétique Moléculaire, CHRU TOURS RCV000133293 SCV001760747 likely pathogenic not provided 2019-10-28 criteria provided, single submitter clinical testing
Suma Genomics RCV000169947 SCV001837627 likely pathogenic X-linked intellectual disability-psychosis-macroorchidism syndrome criteria provided, single submitter clinical testing
Laboratoire de Génétique Moléculaire, CHU Bordeaux RCV000170241 SCV003836688 pathogenic Rett syndrome 2020-06-02 criteria provided, single submitter clinical testing
Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center RCV000170241 SCV003932164 pathogenic Rett syndrome 2023-03-02 criteria provided, single submitter clinical testing PS2_Very Strong, PS4, PM2, PP3
Institute Of Human Genetics Munich, Klinikum Rechts Der Isar, Tu München RCV000170241 SCV004045783 pathogenic Rett syndrome 2023-08-22 criteria provided, single submitter clinical testing
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center RCV003984819 SCV004801240 pathogenic Syndromic X-linked intellectual disability Lubs type 2024-03-14 criteria provided, single submitter research
RettBASE RCV000169947 SCV000188302 uncertain significance X-linked intellectual disability-psychosis-macroorchidism syndrome 2013-12-05 no assertion criteria provided curation
RettBASE RCV000170240 SCV000222571 uncertain significance Autism, susceptibility to, X-linked 3 2013-12-05 no assertion criteria provided curation
RettBASE RCV000170241 SCV000222572 uncertain significance Rett syndrome 2013-12-05 no assertion criteria provided curation
GeneReviews RCV000170241 SCV000998928 not provided Rett syndrome no assertion provided literature only
Section for Clinical Neurogenetics, University of Tübingen RCV000170241 SCV001156091 pathogenic Rett syndrome 2019-08-01 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.